Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Cytokinetics Inc
Nieuws
Cytokinetics Inc
CYTK
NAS
: CYTK
| ISIN: US23282W6057
5/06/2026
71,48 USD
(-1,12%)
(-1,12%)
5/06/2026
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
1 juni 2026 ·
Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
· Persbericht
14 november 2025 ·
CYTK DEADLINE: Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
· Persbericht
14 november 2025 ·
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
· Persbericht
11 november 2025 ·
Shareholders that lost money on Cytokinetics, Incorporated (CYTK) should contact Levi & Korsinsky about pending Class Action - CYTK
· Persbericht
8 november 2025 ·
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
· Persbericht
7 november 2025 ·
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK)
· Persbericht
4 november 2025 ·
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
· Persbericht
3 november 2025 ·
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
· Persbericht
31 oktober 2025 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 17, 2025 in Cytokinetics, Incorporated Lawsuit - CYTK
· Persbericht
28 oktober 2025 ·
Levi & Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
· Persbericht
25 oktober 2025 ·
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
· Persbericht
24 oktober 2025 ·
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
· Persbericht
23 oktober 2025 ·
CYTK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
· Persbericht
21 oktober 2025 ·
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
· Persbericht
21 oktober 2025 ·
Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
· Persbericht
17 oktober 2025 ·
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTK
· Persbericht
15 oktober 2025 ·
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
· Persbericht
11 oktober 2025 ·
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
· Persbericht
10 oktober 2025 ·
Investors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class Action - CYTK
· Persbericht
10 oktober 2025 ·
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe